Recruiting Breast Cancer Studies in Margate
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2....
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
This study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast cancer with brain metastas...
About Breast Cancer Clinical Trials in Margate
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Margate, FLORIDA. These studies are seeking a combined 916 participants. Research is being sponsored by DualityBio Inc., Biostar Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Margate — FAQ
Are there breast cancer clinical trials in Margate?
Yes, there are 2 breast cancer clinical trials currently recruiting in Margate, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Margate?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Margate research site will contact you about next steps.
Are clinical trials in Margate free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Margate studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Margate are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov